Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy
EH Weissler, WS Jones, I Desormais, S Debus… - Atherosclerosis, 2020 - Elsevier
Background and aims Polyvascular disease (PVD) affects approximately 20% of patients
with atherosclerosis and is a strong independent risk factor for ischemic outcomes. However …
with atherosclerosis and is a strong independent risk factor for ischemic outcomes. However …
Polyvascular disease: reappraisal of the current clinical landscape
Atherosclerosis within 2 or more arterial beds has been termed polyvascular disease.
Although polyvascular disease has long been associated with heightened cardiovascular …
Although polyvascular disease has long been associated with heightened cardiovascular …
Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome
S Yakubov - Current medical research and opinion, 2009 - Taylor & Francis
Background: Patients with an initial ischemic event secondary to atherosclerosis have an
increased risk of suffering a recurrent event not only in the same vascular territory, but in …
increased risk of suffering a recurrent event not only in the same vascular territory, but in …
Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial
JA Gutierrez, H Mulder, WS Jones… - JAMA network …, 2018 - jamanetwork.com
Importance The effect of polyvascular disease on cardiovascular outcomes in the
background of peripheral artery disease (PAD) is unclear. Objective To determine the risk of …
background of peripheral artery disease (PAD) is unclear. Objective To determine the risk of …
How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology.
Atherosclerosis is a systemic disease affecting multiple arterial territories. Patients with
clinical atherosclerotic disease in one vascular bed are likely to have asymptomatic or …
clinical atherosclerotic disease in one vascular bed are likely to have asymptomatic or …
[HTML][HTML] Optimization of the pharmacological therapy in patients with poly-vascular disease: a multidisciplinary approach
R Gioscia, C Castagno, M Verdoia, B Conti… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The recent shift of the concept of cardiovascular disease as a chronic progressive condition,
potentially involving multiple districts, has driven attention to the optimal management of …
potentially involving multiple districts, has driven attention to the optimal management of …
Polyvascular disease and risk: When two is not better than one
MP Bonaca - Vascular Medicine, 2018 - journals.sagepub.com
532 Vascular Medicine 23 (6) limb ischemia (ALI), which was similar regardless of
concomitant CAD and underscores that the predictors of MACE and ALI in patients with PAD …
concomitant CAD and underscores that the predictors of MACE and ALI in patients with PAD …
Management of the cardiology patient with polyvascular disease: PRISMA study
M Cournot, JP Cambou, J Ferrieres… - … des Maladies du …, 2004 - europepmc.org
Objective The aim of this work was to describe the clinical characteristics and the medical
management of polyvascular patients in cardiology. Method Cardiologists from all over the …
management of polyvascular patients in cardiology. Method Cardiologists from all over the …
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention
T Miura, Y Soga, T Doijiri, H Aihara, H Yokoi… - Circulation …, 2013 - jstage.jst.go.jp
Background: The goal of this study was to evaluate the prevalence and outcomes of
polyvascular disease (polyVD; defined as lower extremity artery disease, carotid artery …
polyvascular disease (polyVD; defined as lower extremity artery disease, carotid artery …
Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis
I Cavallari, DA Morrow, MA Creager, J Olin, DL Bhatt… - Circulation, 2018 - Am Heart Assoc
Background: Observational studies suggest that symptomatic atherosclerosis may be
associated with risk of venous thromboembolism (VTE). Prior randomized studies have …
associated with risk of venous thromboembolism (VTE). Prior randomized studies have …